Optimization of commercially available Zika virus antibodies for use in a laboratory‐developed immun...
Optimization of commercially available Zika virus antibodies for use in a laboratory‐developed immunohistochemical assay
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Zika virus (ZIKV) infection during pregnancy can cause adverse fetal outcomes and severe irreversible congenital birth defects including microcephaly. Immunohistochemistry (IHC) is a valuable diagnostic tool for detecting ZIKV antigens in tissues from cases of fetal loss in women infected with ZIKV, and for providing insights into disease pathogene...
Alternative Titles
Full title
Optimization of commercially available Zika virus antibodies for use in a laboratory‐developed immunohistochemical assay
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5783976
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5783976
Other Identifiers
ISSN
2056-4538
E-ISSN
2056-4538
DOI
10.1002/cjp2.84
